Perspective - Pharmaceutical Bioprocessing (2025) Volume 13, Issue 5
Real-Time Release Testing: Accelerating Quality Assurance in Biomanufacturing
Julien Moreau*
Dept. of Quality by Design, Sorbonne Tech Institute, France
- *Corresponding Author:
- Julien Moreau
Dept. of Quality by Design, Sorbonne Tech Institute, France
E-mail: j.moreau@sti.fr
Received: 01-Sep-2025, Manuscript No. fmpb-26-184971; Editor assigned: 03-Sep-2025, PreQC No. fmpb-26-184971 (PQ); Reviewed: 17- Sep-2025, QC No. fmpb-26-184971; Revised: 22-Sep-2025, Manuscript No. fmpb-26-184971 (R); Published: 30-Sep-2025, DOI: 10.37532/2048- 9145.2025.13(5).285-286
Introduction
Real-time release testing (RTRT) is an advanced quality assurance approach that enables product release based on real-time process data rather than extensive end-product testing. In traditional biomanufacturing, product release often depends on time-consuming laboratory assays performed after production is complete. RTRT shifts the focus toward continuous monitoring and control of critical process parameters and quality attributes during manufacturing [1,2]. This approach supports faster release timelines, improved process understanding, and enhanced product quality, aligning with modern regulatory expectations and quality-by-design (QbD) principles.
Discussion
The foundation of real-time release testing lies in the integration of process analytical technology (PAT), advanced sensors, and data analytics. By continuously monitoring critical process parameters such as temperature, pH, dissolved oxygen, and nutrient levels, manufacturers can infer product quality attributes in real time. Analytical techniques such as spectroscopy, chromatography, and multivariate data analysis enable the assessment of attributes like concentration, purity, and consistency without the need for extensive offline testing [3,4].
RTRT offers several advantages over traditional release strategies. Real-time monitoring reduces reliance on end-point testing, shortening release timelines and improving supply chain responsiveness. Early detection of deviations allows corrective actions to be taken before product quality is compromised, reducing batch failures and waste. RTRT also supports continuous and intensified manufacturing processes, where traditional batch-based release testing may be impractical [5].
However, implementing RTRT presents technical and regulatory challenges. Robust models must be developed and validated to reliably link process data to product quality attributes. Data integrity, system reliability, and cybersecurity are critical considerations, as real-time decisions rely on continuous data streams. Regulatory authorities require thorough documentation, validation, and lifecycle management of RTRT systems to ensure transparency and compliance.
Advances in automation, digitalization, and artificial intelligence are strengthening RTRT capabilities. Machine learning models can improve predictive accuracy and adapt to process variability over time. Integration with manufacturing execution systems further enhances traceability and decision-making.
Conclusion
Real-time release testing represents a paradigm shift in quality assurance for biomanufacturing. By enabling product release based on real-time process understanding, RTRT improves efficiency, reduces delays, and enhances product quality. While challenges related to validation, data management, and regulatory acceptance remain, ongoing technological advancements and regulatory support are driving wider adoption. As biomanufacturing continues to evolve toward data-driven and continuous processes, real-time release testing will play a central role in ensuring timely and reliable delivery of high-quality biopharmaceutical products.
References
- HAHS, Deshmukhe PV (2010) Bioinsecticidal Potential of Vinca rosea Against the Tobacco Caterpillar, Spodoptera Litura (Fabricius) (Lepidoptera: Noctuidae). Recent Research Science and Technology 1- 5.
- Barik K, Sao S, Parihar DK (2016) Phytochemical and Pharmaceutical Panorama of Catharanthus roseus. IAJPS 3:288-293.
- Ingalwad P, Veer V, Bhosale A (2020) Overview on a Vinca Alkaloid & Its Medicinal, Therapeutic Properties. IJTSRD 4: 846-49.
- Johnson IS, Armstrong JG, Gorman M, Burnett JR (1963) The Vinca Alkaloids: A New Class of Oncolytic Agents. Cancer Res 1390-427.
- Nayak BS, Pereira LMP (2006) Catharanthus roseus flower extract has wound healing activity in Sprague Dawley rats. BMC Complement Altern Med 6:41.
